Sedentary BehaviorNCT06427603
Sit Less and Move More: Feasibility Study
A study testing physical activity in people with Sedentary Behavior, run by Hong Kong Metropolitan University at 1 site in Hong Kong.
Trial summary
Intervention aiming to improve cardiometabolic health and physical function by reducing prolonged sitting Read more about this study
- Who is it for?
- Ages 65 years and olderHealthy volunteers can take part
- Conditions the study is for
- Sedentary Behavior
- What is being tested?
- physical activity
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteHong Kong
- Study dates
- Oct 2025to Feb 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- Healthy volunteers accepted
- Older adult
Who may be able to join
- are community-dwelling older adults aged 65 years or above,
- are smartphone users,
- sit for >= 6 hours per day
- are overweight
Who cannot join
- are unable to walk independently with/without walking aids due to a physical disability;
- have health conditions that hinder the adherence to intervention
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Hong Kong1 site, 1 recruiting
- Recruiting
School of Nursing and Health Studies, Hong Kong Metropolitan University
Ho Man Tin
Bonny YM Wong, PhD, (852) 3970 2976, bymwong@hkmu.edu.hk
Bonny YM Wong, PhD
About this study
Official title: Sit Less and Move More: A Feasibility Study on Physical Active Break Intervention and Improving Cardiometabolic Health
Intervention aiming to improve cardiometabolic health and physical function by reducing prolonged sitting
- Conditions
- Sedentary Behavior
- Being tested
- physical activity
- Medical subject headings
- Sedentary Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
physical activityBehavioural
workshops and mobile apps: break sedentary behavior by activity breaks
| Study group | Role | What they receive |
|---|---|---|
| activity group | Experimental | Not described Receives: Behavioral: physical activity |
What is being measured
The primary outcome is the main question the study is designed to answer.
Intervention feasibility
will be assessed using a scale "Feasibility, appropriateness, and acceptability of the intervention"
Measured: T2: post-intervention (week 12)
Secondary outcomes (18)
Sedentary behavior
will be assessed using an accelerometer
Measured: T1: baseline (before the study begins)
Sedentary behavior
will be assessed using an accelerometer
Measured: T2: post-intervention (week 12)
Sarcopenia score ranged from 0 to 20
will be assessed using the Strength, Assistance with walking, Rise from a chair, Climb stairs and (Calf) Falls (SARC-Calf)
Measured: T1: baseline (before the study begins)
Sarcopenia score ranged from 0 to 20
will be assessed using the Strength, Assistance with walking, Rise from a chair, Climb stairs and (Calf) Falls (SARC-Calf)
Measured: T2: post-intervention (week 12)
Blood glucose
will be assessed using a portable blood monitoring device
Measured: T1: baseline (before the study begins)
Blood glucose
will be assessed using a portable blood monitoring device
Measured: T2: post-intervention (week 12)
Blood pressure
will be assessed using a portable blood monitoring device
Measured: T1: baseline (before the study begins)
Blood pressure
will be assessed using a portable blood monitoring device
Measured: T2: post-intervention (week 12)
Muscle strength (handgrip strength)
will be assessed using a hand-held dynamometer
Measured: T1: baseline (before the study begins)
Muscle strength (handgrip strength)
will be assessed using a hand-held dynamometer
Measured: T2: post-intervention (week 12)
Physical performance
will be assessed using Time-Up-to-Go (TUG)
Measured: T1: baseline (before the study begins)
Physical performance
will be assessed using Time-Up-to-Go (TUG)
Measured: T2: post-intervention (week 12)
physical function
will be assessed using Short physical performance battery (SPPB) ranging 0 to 12
Measured: T1: baseline (before the study begins)
physical function
will be assessed using Short physical performance battery (SPPB) ranging 0 to 12
Measured: T2: post-intervention (week 12)
Physical activity
will be assessed using an accelerometer
Measured: T1: baseline (before the study begins)
Physical activity
will be assessed using an accelerometer
Measured: T2: post-intervention (week 12)
Standing
will be assessed using an accelerometer
Measured: T1: baseline (before the study begins)
Standing
will be assessed using an accelerometer
Measured: T2: post-intervention (week 12)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 May 2024
- Study startOct 2025 (estimated)
- Primary completionJan 2026 (estimated)
- Study completionFeb 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Sedentary BehaviorStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hong Kong Metropolitan University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Dr Bonny WONG Yee Man, Hong Kong Metropolitan University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06427603
- Sponsor's protocol ID
- RD/2022/2.12
- Status last verified
- Sep 2025
- First submitted
- 8 May 2024
- Last updated
- 24 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Sit Less and Move More: A Feasibility Study on Physical Active Break Intervention and Improving Cardiometabolic Health
- ClinicalTrials.gov ID
- NCT06427603
- Acronym / sponsor ID
- RD/2022/2.12
- Conditions
- Sedentary Behavior
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Hong Kong Metropolitan UniversityUniversity, hospital or other
- Study start
- Oct 2025 (estimated)
- Primary completion
- Jan 2026 (estimated)
- Study completion
- Feb 2026 (estimated)
- First posted
- 24 May 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Intervention aiming to improve cardiometabolic health and physical function by reducing prolonged sitting
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| activity group | Experimental | Behavioral: physical activity |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
Key inclusion criteria (4 listed)
- are community-dwelling older adults aged 65 years or above,
- are smartphone users,
- sit for >= 6 hours per day
- are overweight
Key exclusion criteria (2 listed)
- are unable to walk independently with/without walking aids due to a physical disability;
- have health conditions that hinder the adherence to intervention
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| physical activityworkshops and mobile apps: break sedentary behavior by activity breaks | Behavioural | activity group |
Primary outcome
Intervention feasibility
Time frame: T2: post-intervention (week 12)
will be assessed using a scale "Feasibility, appropriateness, and acceptability of the intervention"
18 secondary outcomes
Sedentary behavior
Time frame: T1: baseline (before the study begins)
Sedentary behavior
Time frame: T2: post-intervention (week 12)
Sarcopenia score ranged from 0 to 20
Time frame: T1: baseline (before the study begins)
Sarcopenia score ranged from 0 to 20
Time frame: T2: post-intervention (week 12)
Blood glucose
Time frame: T1: baseline (before the study begins)
Blood glucose
Time frame: T2: post-intervention (week 12)
Blood pressure
Time frame: T1: baseline (before the study begins)
Blood pressure
Time frame: T2: post-intervention (week 12)
Muscle strength (handgrip strength)
Time frame: T1: baseline (before the study begins)
Muscle strength (handgrip strength)
Time frame: T2: post-intervention (week 12)
Physical performance
Time frame: T1: baseline (before the study begins)
Physical performance
Time frame: T2: post-intervention (week 12)
physical function
Time frame: T1: baseline (before the study begins)
physical function
Time frame: T2: post-intervention (week 12)
Physical activity
Time frame: T1: baseline (before the study begins)
Physical activity
Time frame: T2: post-intervention (week 12)
Standing
Time frame: T1: baseline (before the study begins)
Standing
Time frame: T2: post-intervention (week 12)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Sep 2025.
- Individual participant dataSharing planned: No
Related trials for Sedentary Behavior
Enrolling by invitation
Recreational Badminton, Sleep and Melatonin
Sedentary Behavior
Active, not recruiting
Future School of Comprehensive Well-Being
Learning, Comprehensive Wellbeing
RecruitingEarly Phase 1
Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM
Gestational Diabetes, Endothelial Dysfunction
Recruiting
Acute Endocrine Responses to Aerobic and Anaerobic Exercise in Sedentary Women: A Comparative Analysis of Thyroid Hormones and Cortisol
Sedentary Behavior, Acute Exercise
Not yet recruiting
Wearable Ankle Power Training (WearAPT) for Enhanced Mobility in Aging
Sedentary Behavior / Physical Inactivity, Aged
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing physical activity in people with Sedentary Behavior, run by Hong Kong Metropolitan University at 1 site in Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 24 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Bonny Wong, PhD (852 98128768, bymwong@hkmu.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Intervention feasibility (time frame: T2: post-intervention (week 12)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2025.